Interaction of ApoE polymorphism with VEGF genes has been shown to affect cognitive impairment in AD patients as increased levels of Neuropilin 1 (NRP1), a member of VEGF family in AD patients has been shown to be associated with improved cognition in ApoE4 non-carriers. The gene discussed is APOE; the disease is Cognitive impairment.